Level D· Scientific groundwork from lab and animal studiesAnimal StudyPubMed

Combination of Mesenchymal Stromal Cells and Cardiac Stem Cells in a Multilayer Cell Construct Promotes Activation of Notch Signaling and Initiation of Endothelial Differentiation.

Shevchenko EK., Dergilev KV., Tsokolaeva ZI., Beloglazova IB., Molokotina YD., Parfenova EV.

Animal Study on Cardiovascular Disease, published in Bull Exp Biol Med (2019) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Animal Study
Journal
Bull Exp Biol Med (2019)
Country
United States
Reported sample size
—
Source database
PubMed
PMID
30783844
DOI
10.1007/s10517-019-04390-7

Abstract (original English)

We showed the possibility of generating combined tissue-engineered cell consisting of layers of rat cardiac stem cells and mesenchymal stromal cells from the adipose tissue. Cell-cell interaction within the cell sheet promoted proliferation of cardiac stem cells, expression of endothelial differentiation marker ETS1, and Notch signaling activation. The obtained results provide new insights into possible mechanisms of stimulation of endogenous regeneration processes after myocardial damage and demonstrate potential of cell-based cardiomyoplasty with the use of these combined cell sheets.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
AnimalsBasic Helix-Loop-Helix ProteinsCell DifferentiationCell ProliferationCells, CulturedMesenchymal Stem CellsMyocardial InfarctionMyocytes, CardiacRatsRepressor Proteins

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research